TP53 and breast carcinoma: Previous study in breast cancer showed that oncogenic TP53 variants in DNA binding domain (amino acid position 102-292) are associated with reduced survival compared to wild-type TP53 with an exception of Y220C, which is associated with better survival in breast cancer (Olivier et al., 2006).